Other GLP-1/GIP/GCG Triple Agonists in Development Besides retatrutide, several GLP-1/GIP/GCG triple agonists are in early-stage clinical trials (Table 3), though the WL efficacy associated with these medications remains unknown
Peptide therapy is quickly becoming the future of regenerative medicine
Nausea and Digestive Discomfort : Animal studies report gastrointestinal disturbances following BPC-157 administration in higher doses
The consistent effects of the once a day intraperitoneal regimen, or per-oral regimen, continuously in drinking water, support that BPC 157 tendon healing [18,19,20,21,22] and muscle healing [21,35,36,37], noted when either tendon or muscle was transected or detached [18,19,20,21,22], may render to the myotendinous junction healing